Literature DB >> 16260917

Zidovudine-induced pure red cell aplasia presenting after 4 years of therapy.

Robert Weinkove, Savita Rangarajan, Jon van der Walt, Ranjababu Kulasegaram.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16260917     DOI： 10.1097/01.aids.0000191230.60008.69

Source DB:  PubMed          Journal:  AIDS        ISSN： 0269-9370            Impact factor:   4.177


× No keyword cloud information.
  4 in total

1.  Hematological Indices at Birth of Infants of HIV-Positive Mothers Participating in a Prevention of Mother-to-Child Transmission Program.

Authors:  Ijeoma Obumneme-Anyim; Ngozi Ibeziako; Ifeoma Emodi; Anthony Ikefuna; Tagbo Oguonu
Journal:  J Trop Pediatr       Date:  2015-09-27       Impact factor: 1.165

2.  Nevirapine inhibits the anti-HIV activity of CD8+ cells.

Authors:  Lianxing Liu; Lin Wang; Liusheng Huang; Vincent Siu; Fernando Teque; Francesca T Aweeka; Jay A Levy
Journal:  J Acquir Immune Defic Syndr       Date:  2013-06-01       Impact factor: 3.731

3.  Zidovudine-induced reversible pure red cell aplasia.

Authors:  Anuja Balakrishnan; Rohith Valsalan; Shubha Sheshadri; Vinay R Pandit; Vikas Medep; Ravindra Kumar Agrawal
Journal:  Indian J Pharmacol       Date:  2010-06       Impact factor: 1.200

4.  INCIDENCE OF ANAEMIA AMONG HIV-INFECTED PATIENTS TREATED WITH ZIDOVUDINE-CONTAINING ANTIRETROVIRAL THERAPY IN NORTHEASTERN NIGERIA.

Authors:  N Y Ikunaiye; B A Denue; B A Aina; R Aderemi-Williams; H E Rawizza
Journal:  Ann Ib Postgrad Med       Date:  2018-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.